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Abstract There have been conflicting reports regarding the
role of ethanol in seizure. Another effect of ethanol is vascular
damage in cerebral tissue. This study investigates the influ-
ence of ethanol on antiepileptic efficacy of valproic acid
(VPA) and cerebral microvascular structure. In this study,
four groups of mice (25–30 g) received pentylenetetrazole
(PTZ) i.p. (37 mg/kg) every other day. Different groups of
animals received an injection of saline, ethanol (1 g/kg), VPA
(100 mg/kg), or VPA and ethanol 30 min before PTZ. Ani-
mals in groups 5 and 6 received only ethanol and saline,
respectively. After recording seizure parameters, the animals
were sacrificed under deep anesthesia and the brains of the
animals were removed and fixed, thereafter coronal sections
were prepared from cerebral cortex. Then, the cerebral
microvessels were counted in microscopic sections after
hematoxylin–eosin staining. Ethanol injection (1 g/kg) for
7 days decreased stage 4 duration and increased latency to the
onset of stage 1 and stage 4 of seizure (p \ 0.001). Con-
comitant injection of VPA (5 min before ethanol) and ethanol
had significantly stronger anticonvulsant effects than VPA
alone (p \ 0.001). Furthermore, the findings showed that not
only the cerebral microvessels increased significantly in
ethanol group compared with saline group (p \ 0.05), but
also there were morphological changes in vascular endothe-
lium in ethanol group. The obtained results show that short-
term ethanol administration has anticonvulsant effects along
with VPA, and enhances the anticonvulsant effects of VPA.
Furthermore, it is possible that VPA leads to decreased
ethanol-induced vascular damage.
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Introduction
Epilepsy is a common neurological disorder characterized
by recurrent, unpredictable seizures with a prevalence rate
of about 1 % [1]. A great deal of research is currently being
conducted to reveal the mechanisms underlying epilepsy
and also to find more effective drugs for epilepsy treat-
ment. The available antiepileptic medications can be
effective in the seizures in only about 40 % of cases, and
they merely reduce the frequency of convulsions in other
cases [2]. Laboratory models for epilepsy induction make it
possible to analyze the mechanisms and predisposing fac-
tors of epilepsy and also to evaluate anticonvulsive drugs
and treatment modalities. One of these models is the
pentylenetetrazole (PTZ) kindling model [3, 4]. In this
model of kindling, following repeated daily injections at
the sub-threshold dosage of PTZ (37 mg/kg), seizure stages
occur in succession [3].
Like many other diseases, risk factors should be con-
sidered for this neurological disorder. Alcohol consump-
tion is one of the risk factors for this disease [5, 6]. Alcohol
consumption is relatively common, particularly in indus-
trialized countries. In 2002, about 40 % of 25- to 34-year-
old Americans consumed alcohol at least five times per
R. Golmohammadi
Department of Anatomy, Cellular and Molecular Research
Center, School of Medicine, Sabzevar University of Medical
Sciences, Sabzevar, Iran
A. Pejhan  M. Mohammad-Zadeh (&)
Department of Physiology, Cellular and Molecular Research
Center, Sabzevar University of Medical Sciences, Sabzevar, Iran
e-mail: mohamad1353@gmail.com
H. Azhdari-Zarmehri
Cellular and Molecular Research Center,
Qazvin University of Medical Sciences, Qazvin, Iran
123
Neurol Sci (2013) 34:1125–1131
DOI 10.1007/s10072-012-1190-y
month. The rate of consumption in younger population
(18–24 years old) was about 51 % [7]. Another study
showed that 77 % of men and 65 % of women in the USA
reported alcohol consumption in 2001 [8].
There are contradictory reports about the effect of
alcohol on epileptic seizures. Some studies reported an
increase in frequency and severity of seizures in mice after
alcohol consumption [9–11]. Conversely, other studies
demonstrate that ethanol has an anticonvulsant effect [5,
12]. In most cases, this anticonvulsant effect occurs in
short-term periods of alcohol consumption. There are also
some studies reporting that alcohol had no effect on epi-
leptic seizures. In non-alcoholic epileptic patients, low to
moderate alcohol consumption had no effect on convul-
sions [6, 13, 14]. A wide range of fetal abnormalities,
especially in the nervous system, have been reported to be
caused by alcohol consumption [6, 15, 16]. Furthermore, it
has been shown recently that alcohol consumption can
impair the blood–brain barrier [17].
Valproic acid (sodium valproate; VPA) is one of the
widely used antiepileptic drugs [18]. More recent studies
report that VPA plays a role in inhibiting the death of pro-
genitor cells producing neurons [19]. However, it is not
perfectly clear whether VPA affects the cerebral microvas-
cular structure in animals with PTZ-induced seizure receiv-
ing ethanol. In addition, in view of the fact that there are few
reports regarding the effect of ethanol on the efficacy of
antiepileptic drugs, this study was designed to investigate the
impact of ethanol on the anticonvulsant effect of VPA and
cerebral microvessel numbers after epileptogenesis in mice.
Methods
Animals
Forty male albino BALB/c mice (25–30 g), obtained from
the animal house of Sabzevar University of Medical Sci-
ences, were maintained in a colony room kept at a constant
temperature on 12:12 light:dark schedule. The animals
were individually housed in plastic cages with woodchip
bedding and permitted free access to food and water.
Procedures involving animals and their care were con-
ducted in accordance with the ‘‘Guide to the Care and Use
of Experimental Animals’’ [20]. All experiments were done
at the same time (8:00 a.m. to 2:00 p.m.) in the morning to
avoid the bias of circadian rhythms [21, 22].
Chemicals
Ethanol and sodium valproate were provided by Sigma
Chemical Co. (St. Louis, MO, USA). All other chemicals
were purchased from common commercial suppliers.
Chemical kindling in mice
Pentylenetetrazole was administered at a subconvulsant
dose of 37 mg/kg on alternate days for a period of 24 days
in control mice. PTZ injections were repeated 12 times.
After each PTZ injection, the animal was placed in a
chamber (30 9 40 9 40 cm) and their behavior was
observed for 20 min. Convulsive responses to PTZ
administration were classified as follows [3]: stage 0, no
responses; stage 1, nodding or head clonus; stage 2, sali-
vation and forelimb clonus; stage 3, spreading hind limbs
and rearing on hind limbs; stage 4, falling backward or
sideward with loss of righting reflex.
Experimental groups
Mice were divided into six groups. The control group (the
first group) received vehicle (saline 0.9 %) 30 min before
intraperitoneal PTZ; the second group was treated with
ethanol (1 g/kg); the third group received VPA (100 mg/
kg), and the fourth group received VPA and ethanol (1 g/
kg). In these four groups, each experimental group had eight
mice. The last groups (groups 5 and 6) received ethanol
(n = 4) or saline (n = 4) alone. All animals, except the fifth
and sixth groups, were injected with PTZ, 30 min after any
intervention. Animals in group 2 (PTZ ? ethanol) received
ethanol for 7 days. Mice in group 3 received valproic acid
along with 12 alternate-day injections of PTZ. In group 4,
the animals received ethanol and VPA for 7 days (VPA
5 min before ethanol) and after that, they received only
valproic acid 30 min before PTZ similar to group 3.
Sample preparation and histology
At the end of the experiment, the mice were deeply anes-
thetized with ether and perfused with saline and formalin
10 %. Their brains were removed and placed in 10 % for-
malin for at least 24 h at room temperature. The samples were
fixed in formalin, dehydrated in a graded series of ethanol (30,
50, 70, 95, and 100 %), and treated with xylol for clearing.
The slices from cortex were then embedded in paraffin.
Sections of 5-lm thickness were prepared using a microtome
(Leica Instruments, Germany) and stained with hematoxylin–
eosin. Under a light microscope (Motic), 35 fields were
selected using systematic random sampling for microvascular
numbers counting. Microvessel counting was performed in a
square measuring 0.64 mm2. Microvessels were identified
based on the absence of smooth muscle layer [23].
Statistical analysis
Data analysis was performed using SPSS statistical soft-
ware package, version 11.5. Results were expressed as
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mean ± standard error of the mean (SEM) and number of
observations. One-way analysis of variance (ANOVA) and
Dunnett test were used for statistical analysis. The basis of
all decisions was a significance level of p \ 0.05.
Results
Effect of ethanol injection on seizure parameters
During the 24-day period when PTZ was injected on
alternate days, ethanol injection for 7 days decreased
stage 4 duration (S4D) of seizure significantly compared
with PTZ ? saline group (F(11,44) = 33.3, p \ 0.001)
(Fig. 1). Ethanol injection (1 g/kg) for 7 days increased
stage 4 latency (S4L) significantly during 12 PTZ injec-
tions compared with PTZ ? saline group (F(11,99) = 1.6,
p \ 0.05) (Fig. 2). Furthermore, the results showed that
ethanol injection (1 g/kg) for 7 days increased stage 1
latency (S1L) significantly during 12 PTZ injections
compared with PTZ ? saline group (F(11,154) = 4.4,
p \ 0.001).
Ethanol decreased mean seizure stage during 12 injec-
tions compared with PTZ ? saline group. For this para-
meter, data are expressed in three points (at the third,
seventh, and twelfth PTZ injections). Mean seizure stage in
PTZ ? saline group increased from 3.7 ± 0.3 (after the
third PTZ injection) to 5 (after the twelfth PTZ injection). In
PTZ ? ethanol group, mean seizure stage decreased from
2.24 ± 0.4 (after the third PTZ injection) to 2.2 ± 0.5
(after the twelfth PTZ injection). The non-parametric
Mann–Whitney U test showed that ethanol significantly
decreased this parameter compared with PTZ ? saline
group after the third (p \ 0.05), seventh (p \ 0.01), and
twelfth (p \ 0.01) PTZ injections (Table 1).
Effect of VPA injection on seizure parameters
Compared with PTZ ? saline group, VPA injection (PTZ ?
VPA group) caused a significant decrease (by 39 %) in S4D
(F(9,45) = 17, p \ 0.001), a significant increase (216.8 %) in
S4L (F(9,81) = 3.5, p \ 0.001), and also a significant increase
in S1L (149 %) (F(9,126) = 1.9, p \ 0.05) (Fig. 3). Mean
seizure stage in PTZ ? VPA group reached 1.8 ± 0.5 after
the twelfth PTZ injection, showing a significant decrease
compared with PTZ ? saline group (5 ± 0) (Table 1).
Effect of VPA and ethanol injection
on seizure parameters
The S4D parameter decreased significantly in PTZ ?
VPA ? ethanol group compared with PTZ ? ethanol
group (47 %) (F(9,117) = 9.2, p \ 0.001), as well as
PTZ ? VPA group (57.1 %) (F(9,99) = 6.5, p \ 0.001)
(Fig. 1). In addition, the S4L parameter in PTZ ? VPA ?
ethanol group showed a 233.9 % increase compared with
PTZ ? VPA group (F(9,99) = 4.4, p \ 0.001) and a 450 %
increase compared with PTZ ? ethanol group (F(9,126) =
27, p \ 0.001) (Fig. 2).
In PTZ ? VPA ? ethanol group, mean seizure stage
after the twelfth PTZ injection was 1.6 ± 0.4, showing no
statistically significant difference when compared with
PTZ ? VPA group (1.8 ± 0.5) or PTZ ? ethanol group
(2.2 ± 0.5) (Table 1).
Fig. 1 Cumulative seizure stage 4 duration (cS4D) in 12 PTZ
injections. In PTZ ? VPA ? ethanol group, VPA was injected 5 min
before ethanol. Ethanol injection for 7 days decreased cS4D signif-
icantly. VPA injection decreased cS4D compared with PTZ ? saline
group significantly, but it showed no significant difference with
ethanol. Concomitant VPA and ethanol injection decreased cS4D, but
the difference with PTZ ? VPA group was not statistically signif-
icant. ***p \ 0.001 compared with PTZ ? saline group. Data are
expressed as mean ± SEM (n = 8)
Fig. 2 Latency to the onset of stage 4 seizure (S4L) (cumulative) in
12 PTZ injections shown as reverse value. In PTZ ? VPA ? ethanol
group, VPA was injected 5 min before ethanol. Ethanol injection for
7 days decreased 1/S4L significantly. Injection of VPA decreased
1/S4L significantly compared with PTZ ? saline group, but had no
significant difference with ethanol group. Concomitant VPA and
ethanol injection decreased 1/S4L significantly compared with PTZ ?
VPA (p = 0.03) and PTZ ? ethanol (p = 0.003) groups. ***p \
0.001 compared with PTZ ? saline group. $p \ 0.05 compared with
PTZ ? VPA group. ##p \ 0.01 compared with PTZ ? ethanol group.
Data are expressed as mean ± SEM (n = 8)
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Effect of ethanol and VPA on mean cerebral
microvessel numbers
There was no difference in mean cerebral microvessel
numbers between PTZ ? saline (2 ± 0.96) and saline
groups (1.7 ± 0.77). Mean cerebral microvessel numbers
in PTZ ? ethanol (2.4 ± 1.06) and PTZ ? VPA (2.5 ±
1.03) groups were significantly different from PTZ ? saline
group (p \ 0.05). On the other hand, mean cerebral
microvessel numbers in ethanol group were increased
(2.2 ± 0.96) relative to saline group (1.7 ± 0.77)
(p \ 0.05). Also, concomitant injection of ethanol and
VPA in PTZ ? VPA ? ethanol group decreased cerebral
microvessel numbers significantly relative to PTZ ? VPA
and PTZ ? ethanol groups (p \ 0.5) (Table 2).
Pathological findings of cerebral microvessels In
PTZ ? ethanol group, not only pathological changes,
including thrombosis, and evident inflammatory reactions,
but also considerable margination of blood cells was
observed in endothelial walls of cerebral microvessels
(Fig. 4e). In contrast, these changes were not observed in
the PTZ ? saline (Fig. 4a) and saline (Fig. 4b) groups.
Similarly, the animals in PTZ ? VPA group showed no
morphological changes, though the luminal diameter of
cerebral blood vessels was larger in this group than the
PTZ ? saline group (Fig. 4c). In PTZ ? VPA ? ethanol
group, vascular morphological changes and proliferation of
endothelial cells were observed, but there was no vascular
thrombosis (Fig. 4d).
Discussion
This study showed that ethanol injection (1 g/kg) for
7 days had anticonvulsant effects (it decreased S4D and
increased S1L and S4L). Concomitant injection of ethanol
and VPA not only decreased PTZ-induced seizures con-
siderably, but also inhibited the increase in microvessel
Table 1 Effect of ethanol, VPA and VPA ? ethanol injection 30 min before PTZ application on the weekly average of seizure stage
Seizure stage PTZ ? saline PTZ ? ethanol PTZ ? VPA PTZ ? VPA ? ethanol
After 3rd injection 3.7 ± 0.3 2.2 ± 0.4* 2.2 ± 0.5* 0.7 ± 0.3***,$,#
After 7th injection 4.1 ± 0.3 2.1 ± 0.3** 2 ± 0.5** 1 ± 0.3**
After 12th injection 5 ± 0 2.2 ± 0.5** 1.8 ± 0.5** 1.6 ± 0.4**
Data are expressed as mean ± SEM (n = 8)
* p \ 0.05, ** p \ 0.01, and *** p \ 0.001 compared with PTZ ? saline group, respectively
# p \ 0.05 compared with PTZ ? ethanol group
$ p \ 0.05 compared with PTZ ? VPA group
Fig. 3 Latency to the onset of stage 1 seizure (S1L) (cumulative) in
12 PTZ injections shown as reverse value. In PTZ ? VPA ? ethanol
group, VPA was injected 5 min before ethanol. Ethanol injection for
7 days decreased 1/S1L significantly. Injection of VPA decreased
1/S1L significantly compared with PTZ ? saline group, but had no
significant difference with ethanol group. Concomitant VPA and
ethanol injection decreased 1/S1L significantly compared with
PTZ ? saline group, but had no significant difference with PTZ ?
VPA or PTZ ? ethanol group. ***p \ 0.001 compared with
PTZ ? saline group. Data are expressed as mean ± SEM (n = 8)
Table 2 Effect of ethanol, VPA and VPA ? ethanol injection 30 min before PTZ injection on cerebral microvessel numbers
Groups
PTZ ? saline PTZ ? ethanol PTZ ? VPA PTZ ? VPA ? ethanol Ethanol Saline
Microvessel numbers 2 ± 0.96 2.4 ± 1.06* 2.5 ± 1.03* 1.9 ± 1.33$ 2.2 ± 0.96# 1.7 ± 0.77
Data are expressed as mean ± SEM
* p \ 0.05 compared with PTZ ? saline group
# p \ 0.05 compared with saline group
$ p \ 0.05 compared with PTZ ? VPA and PTZ ? ethanol groups
1128 Neurol Sci (2013) 34:1125–1131
123
numbers caused by PTZ and ethanol alone and the vascular
damage induced by PTZ.
The findings of this study are compatible with studies
that report anticonvulsant effects for ethanol [9, 12, 24]. On
the other hand, some studies have reported that ethanol is a
proconvulsant. There are reports indicating that chronic
alcohol consumption can increase the severity and fre-
quency of convulsions [11, 25]. Also it has been shown that
ethanol does not have any effect on seizures [6]. In fact, one
reason for discrepancies in the effects of ethanol in various
studies could be the difference in the number of daily
injections and the type of epileptogenic agent used in those
studies. The antiepileptic effect of VPA is thought to be due
to the fact that VPA increases GABA levels in the brain and
is able to block sodium channels [18]. In this way, VPA
decreases the frequency and severity of seizure, since
GABA is the most important inhibitory neurotransmitter in
the brain [26]. On the other hand, one mechanism for the
action of ethanol is through stimulation of GABA receptors
[5]. Consequently, both compounds (VPA and ethanol)
seem to act via the same pathway and so the inhibitory
effect is stronger in PTZ ? VPA ? ethanol group. In
accordance with these findings, it has been shown that
concomitant injection of ethanol and VPA has no effect on
blood concentration of VPA [5]. In other words, ethanol not
only does not decrease VPA blood concentration, but also
acts as an anticonvulsant and inhibits the progression of
seizure to a greater extent than when taking VPA alone. In
line with these results, it has been shown that in maximal
electroshock-induced seizure and PTZ-induced seizure
models, acute consumption of ethanol decreases ED50 of
valproic acid, but chronic consumption of ethanol has no
effect [27]. This means that acute consumption of ethanol
enhances the anticonvulsant effect of VPA. Also in the
Fig. 4 Coronal 5-lm section of the cortex stained with hematoxylin–
eosin in experimental groups. Arrows indicate endothelium and lumen
of microvessels (a, b and c), proliferation of endothelial cells (d) and
microvascular thrombosis (e). In PTZ ? saline (a) and saline
(b) groups, microvascular morphology was normal. In PTZ ? VPA
group (c), microvascular diameter was larger than PTZ ? saline
group. In PTZ ? VPA ? ethanol group (d), proliferation of endo-
thelial cells was observed. In PTZ ? ethanol group (E), thrombosis
and margination of blood cells have been shown. Magnification
9400. Scale bar 50 lm
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present study, the anticonvulsant effect of VPA was rein-
forced by the presence of ethanol.
In a study by Shiu et al. [28] on endothelial cells of human
brain vessels, it was shown that ethanol causes vascular
dysfunction and increases diffusion of blood components
across endothelial cell membranes. In the current study,
even though the animals receiving ethanol alone showed an
increase in cerebral microvessel numbers, they had no
indication of inflammatory reactions. On the other hand,
PTZ ? ethanol group showed both increased microvessels
and inflammatory reactions. Actually, this finding shows
that the blood–brain barrier is more vulnerable in the pres-
ence of both ethanol and PTZ. Since the structural changes
of cerebral microvessels have a significant effect on neu-
ronal function, these changes can lead to promotion or
inhibition of epileptic seizures. For example, it has been
shown that ischemia is a predisposing factor for develop-
ment of seizures [18, 29]. On the other hand, some studies
report an increase in angiogenesis during convulsions in
epileptic patients [30]. It seems that decreased blood flow
leads to excitation of neurons and development of seizures
and the nervous system promotes angiogenesis during
convulsions as a compensatory mechanism. The present
study showed increased angiogenesis in PTZ ? saline
group, which can be justified by increased angiogenesis in
epileptic subjects. Furthermore, PTZ ? ethanol ? VPA
group showed no significant difference with saline or
PTZ ? saline group. It seems that this absence of changes is
due to treatment and inhibition of seizures by both ethanol
and VPA, thus preventing the induction of the compensatory
mechanism of angiogenesis by the nervous system.
Some studies attribute ethanol-induced cellular damage
to induction of enzymes activated in oxidative reactions,
such as P450-2E1. Although the mechanism of action of
alcohol on endothelial cells of cerebral vessels is not fully
understood, it seems that increased stress reactions in
vascular endothelial cells lead to dysfunction of the blood–
brain barrier [30]. The fact that, in the present study, the
effect of ethanol was stronger in PTZ ? ethanol group than
in the group receiving ethanol alone raises the question of
whether ethanol acts synergistically with PTZ in damaging
endothelial cells of cerebral vessels. More research is
needed to answer this question, but it can be said that
animals with PTZ-induced seizures are more susceptible to
the effects of ethanol. Haorah and colleagues [31] showed
that ethanol impairs IP3 receptors, leading to release of
calcium, which can cause neuronal death. In the present
study, no inflammatory reaction was observed in
PTZ ? VPA ? ethanol group. Therefore, it seems that
VPA has been partially effective in repairing ethanol-
induced damage to vascular endothelial cells. A report by
Shang and colleagues [32] shows that VPA decreases
cytokines involved in inflammatory reactions. This finding
is compatible with the present study. Therefore, another
contribution of this research is that VPA may partially
prevent more vascular damage in patients with alcohol
dependency. In accordance with this finding, it has been
shown that VPA acts as a useful anticancer drug for
treating patients with malignancy (VPA easily crosses the
blood–brain barrier) [33].
In conclusion, according to the present results, it may be
postulated that concomitant injection of ethanol and VPA
has stronger anticonvulsant effects on PTZ-induced sei-
zures. Also simultaneous use of ethanol and VPA inhibited
the increase in microvessel numbers caused by seizure
propagation and ethanol consumption alone, as well as the
vascular damage induced by the epileptic disorder. Since
VPA is an important antiepileptic agent and alcohol use is
relatively prevalent, it is proposed that more cellular and
molecular studies should be conducted to characterize the
interaction effects of these drugs in epileptic disorders.
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